01/10/2019 | News release | Distributed by Public on 01/11/2019 10:12
Counsyl, Inc. is now Myriad Women's Health, Inc., a premier genetic screening and personalized medicine testing company
Our genetic screens and tests provide actionable information, empowering women and their families to make critical and timely healthcare decisions, whether they're thinking about starting a family or evaluating risk for hereditary cancer.
We strive to put patients first, put clinicians in control and put costs in their place. We seek to transform the execution of complex genetic testing and screening through our three high-value products, which include end-to-end workflow features making for seamless delivery of Myriad products to patients.
myRisk® Hereditary Cancer
Help patients get ahead of cancer with our hereditary cancer test.
Foresight® Carrier Screen
Unmatched detection of at-risk couples for serious conditions.
PrequelTM Prenatal Screen
Reliable results, the first time with our noninvasive prenatal screen.
A proprietary suite of solutions, designed to deliver high quality care to every patient when it comes to Myriad Women's Health products, without additional burden on your practice.
Visit our website to learn more about Myriad Women's Health, our vision, and our offerings.